Study of the Blood Concentrations of Two Formulations of REGN2222 in Healthy Subjects

NCT02828397 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: REGN2222

Sponsor

Regeneron Pharmaceuticals